Localization of TFPI-2 in the nucleus modulates MMP-2 gene expression in breast cancer cells

[1]  Rong-Fong Shen,et al.  NAG-1/GDF15 Accumulates in the nucleus and modulates transcriptional regulation of the Smad pathway , 2015, Oncogene.

[2]  W. Gu,et al.  Specific interaction of KIF11 with ZBP1 regulates the transport of β-actin mRNA and cell motility , 2015, Journal of Cell Science.

[3]  Lu-Lu Zhai,et al.  Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinoma. , 2015, International journal of clinical and experimental pathology.

[4]  Dimitris Georgiadis,et al.  A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity , 2014, Nature Medicine.

[5]  W. Gu,et al.  Specific interaction of KIF 11 with ZBP 1 regulates the transport of β-actin mRNA and cell motility , 2014 .

[6]  N. Heuzé-Vourc’h,et al.  Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer☆ , 2013, FEBS open bio.

[7]  Duan Ma,et al.  Low expression of TFPI-2 associated with poor survival outcome in patients with breast cancer , 2013, BMC Cancer.

[8]  A. Tamašauskas,et al.  Associations between TFPI-2 methylation and poor prognosis in glioblastomas. , 2012, Medicina.

[9]  M. Sirover,et al.  Subcellular dynamics of multifunctional protein regulation: Mechanisms of GAPDH intracellular translocation , 2012, Journal of cellular biochemistry.

[10]  Duan Ma,et al.  The interaction of the second Kunitz-type domain (KD2) of TFPI-2 with a novel interaction partner, prosaposin, mediates the inhibition of the invasion and migration of human fibrosarcoma cells. , 2012, The Biochemical journal.

[11]  S. Kojima,et al.  New insights into the functions and localization of nuclear transglutaminase 2 , 2011, The FEBS journal.

[12]  Yong Xu,et al.  Tissue factor pathway inhibitor-2 inhibits the growth and invasion of hepatocellular carcinoma cells and is inactivated in human hepatocellular carcinoma. , 2011, Oncology letters.

[13]  Y. Gruel,et al.  TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions , 2009, Journal of cellular and molecular medicine.

[14]  H. Ryoo,et al.  The odontogenic ameloblast‐associated protein (ODAM) cooperates with RUNX2 and modulates enamel mineralization via regulation of MMP‐20 , 2010, Journal of cellular biochemistry.

[15]  W. Kisiel,et al.  Human tissue factor pathway inhibitor-2 is internalized by cells and translocated to the nucleus by the importin system. , 2009, Archives of biochemistry and biophysics.

[16]  J. Dietl,et al.  Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature , 2009, BMC Cancer.

[17]  Nong Zhang,et al.  Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells , 2007, BMC Molecular Biology.

[18]  W. Kisiel,et al.  The role of tissue factor pathway inhibitor-2 in cancer biology. , 2007, Seminars in thrombosis and hemostasis.

[19]  P. Sismondi,et al.  The AP-2alpha transcription factor regulates tumor cell migration and apoptosis. , 2007, Advances in experimental medicine and biology.

[20]  N. Planque,et al.  Nuclear trafficking of secreted factors and cell-surface receptors: new pathways to regulate cell proliferation and differentiation, and involvement in cancers , 2006, Cell Communication and Signaling.

[21]  E. Lemarié,et al.  Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer , 2005, British Journal of Cancer.

[22]  W. Kisiel,et al.  The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice. , 2004, Blood.

[23]  W. Kisiel,et al.  Distribution of the Human Intracellular Serpin Protease Inhibitor 8 in Human Tissues , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[24]  P. Bird,et al.  Nucleocytoplasmic Distribution of the Ovalbumin Serpin PI-9 Requires a Nonconventional Nuclear Import Pathway and the Export Factor Crm1 , 2001, Molecular and Cellular Biology.

[25]  P. Libby,et al.  Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. , 2001, The Journal of clinical investigation.

[26]  G. Fuller,et al.  Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  Junseo Oh,et al.  Tissue factor pathway inhibitor‐2 suppresses the production of active matrix metalloproteinase‐2 and is down‐regulated in cells harboring activated ras oncogenes , 2000, FEBS letters.

[28]  M. Duffy,et al.  Metalloproteinases: role in breast carcinogenesis, invasion and metastasis , 2000, Breast Cancer Research.

[29]  E. Benveniste,et al.  The Transcription Factors Sp1, Sp3, and AP-2 Are Required for Constitutive Matrix Metalloproteinase-2 Gene Expression in Astroglioma Cells* , 1999, The Journal of Biological Chemistry.

[30]  R. Schleef,et al.  Identification of a Nuclear Targeting Domain in the Insertion between Helices C and D in Protease Inhibitor-10* , 1999, The Journal of Biological Chemistry.

[31]  T. Murakami,et al.  Localization of a serine proteinase inhibitor, B-43, in the bovine pancreas , 1998, Histochemistry and Cell Biology.

[32]  M. Stack,et al.  HT‐1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix‐associated serine protease inhibitor TFPI‐2/33 kDa MSPI , 1998, International journal of cancer.

[33]  W. Kisiel,et al.  Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[34]  A. Rizzino,et al.  Appearance of nuclear protease activity after embryonal carcinoma cells undergo differentiation. , 1996, Developmental biology.

[35]  Y. Miyagi,et al.  cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2. , 1994, Journal of biochemistry.